Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Biomarkers for Early Diagnosis of Dementia"
Deadline for manuscript submissions: closed (30 November 2019).
2. Center for Behavioral Brain Sciences, Magdeburg, Germany;
3. Otto von Guericke University, Medical Faculty, Dpt. of Neurology, Magdeburg, Germany
Interests: dementia prevention; early diagnosis; cognitive interactions; training; neurophysiology
Special Issues and Collections in MDPI journals
Interests: Cognitive Neuroscience; Neuroimaging; Memory; Cognitive Neuropsychology
Early (and accurate) diagnosis of dementia is essential both to patients and to research. For the patients, an early diagnosis can help them take control of their condition, plan for the future and live well with dementia. For research, early diagnosis has become a major issue since so many clinical trials with new, potentially disease-modifying drugs have failed in patients at later stages of disease, i.e. when the clinical symptoms of dementia are already interfering with everyday life. It is now widely believed that at this late stage the pathological brain changes and cognitive impairments are already irreversible. Hence, there is a strong need to detect signs of dementia (especially Alzheimer's) earlier, namely at the preclinical or prodromal stage when the typical symptoms are yet to emerge. This early detection is necessary in order for any upcoming disease modifying therapy or prevention approach to be effective. In order to account for this clinical need we have launched this Special Issue. The issue aims at identifying new methods for the early (i.e. sensitive) and accurate (i.e. specific) detection of dementias of all types. The methods can come from various fields, e.g. neuroimaging, biomarkers from blood or CSF, as well as new, more elaborate tests to detect early cognitive deficits. The cost-effectiveness and side effects of the suggested methods are also important factors that need to be considered.
Prof. Dr. Notger Müller
Dr. Marlen Schmicker
Dr. Wenzel Glanz
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cognitive impairments